TIGIT expression was found to be upregulated in various immune cells after MWA, and combining TIGIT blockade with MWA significantly enhanced the expansion and functionality of CD8+ tumor-infiltrating lymphocytes (TILs) and reshaped myeloid cells in the tumor microenvironment (37). The gene discussed is CD8A; the disease is neoplasm.